SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material:
SEC Accession No. 0001193125-19-129395
Filing Date
2019-04-30
Accepted
2019-04-30 16:18:02
Documents
1
Effectiveness Date
2019-04-30

Document Format Files

Seq Description Document Type Size
1 DEFA14A d738492ddefa14a.htm DEFA14A 29800
  Complete submission text file 0001193125-19-129395.txt   30982
Mailing Address C/O NIGHTSTAR, INC. 203 CRESCENT STREET, SUITE 303 WALTHAM MA 02453
Business Address C/O NIGHTSTAR, INC. 203 CRESCENT STREET, SUITE 303 WALTHAM MA 02453 781-778-7553
Nightstar Therapeutics plc (Filer) CIK: 0001711675 (see all company filings)

IRS No.: 000000000 | State of Incorp.: X0 | Fiscal Year End: 1231
Type: DEFA14A | Act: 34 | File No.: 001-38217 | Film No.: 19781990
SIC: 2836 Biological Products, (No Diagnostic Substances)